Literature DB >> 18204267

Classical forms of congenital adrenal hyperplasia due to 21-hydroxylase deficiency in adults.

Anne Bachelot1, Zeina Chakthoura, Agnès Rouxel, Jérome Dulon, Philippe Touraine.   

Abstract

During childhood, the main aims of the medical treatment of congenital adrenal hyperplasia (CAH) secondary to 21-hydroxylase are to prevent salt loss and virilization and to attain normal stature and normal puberty. As such, there is a narrow therapeutic window through which the intended results can be achieved. In adulthood, the clinical management has received little attention, but recent studies have shown the relevance of long-term follow-up of these patients. The aims here are to review the multiple clinical, hormonal and metabolic abnormalities that could be found in adult CAH patients as such a decrease in bone mineral density, overweight and disturbed reproductive functions. In women with classic CAH, a low fertility rate is reported, and is probably the consequence of multiple factors including neuroendocrine and hormonal factors, feminizing surgery, and psychological factors. Men with CAH may present hypogonadism either through the effect of adrenal rests or from suppression of gonadotropins resulting in infertility. Therefore a multidisciplinary team with knowledge of CAH should carefully follow up these patients, from childhood through to adulthood, to avoid these complications and to ensure treatment compliance and tight control of the adrenal androgens. (c) 2008 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18204267     DOI: 10.1159/000113020

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  9 in total

1.  Nonclassic congenital adrenal hyperplasia.

Authors:  Selma Feldman Witchel; Ricardo Azziz
Journal:  Int J Pediatr Endocrinol       Date:  2010-06-30

Review 2.  [Testicular adrenal rest tumors (TART) in adult men with classic congenital adrenal hyperplasia (CAH)].

Authors:  P Knape; N Reisch; H-G Dörr; M Reincke; S Lenk; M Quinkler
Journal:  Urologe A       Date:  2008-12       Impact factor: 0.639

3.  Guidelines for the Development of Comprehensive Care Centers for Congenital Adrenal Hyperplasia: Guidance from the CARES Foundation Initiative.

Authors:  Richard J Auchus; Selma Feldman Witchel; Kelly R Leight; Javier Aisenberg; Ricardo Azziz; Tânia A Bachega; Linda A Baker; Arlene B Baratz; Laurence S Baskin; Sheri A Berenbaum; David T Breault; Barbara I Cerame; Gerard S Conway; Erica A Eugster; Stephanie Fracassa; John P Gearhart; Mitchell E Geffner; Katharine B Harris; Richard S Hurwitz; Aviva L Katz; Brinda N Kalro; Peter A Lee; Gretchen Alger Lin; Karen J Loechner; Ian Marshall; Deborah P Merke; Claude J Migeon; Walter L Miller; Tamara L Nenadovich; Sharon E Oberfield; Kenneth A Pass; Dix P Poppas; Michele A Lloyd-Puryear; Charmian A Quigley; Felix G Riepe; Richard C Rink; Scott A Rivkees; David E Sandberg; Traci L Schaeffer; Richard N Schlussel; Francis X Schneck; Ellen W Seely; Diane Snyder; Phyllis W Speiser; Bradford L Therrell; Carol Vanryzin; Maria G Vogiatzi; Michael P Wajnrajch; Perrin C White; Alan E Zuckerman
Journal:  Int J Pediatr Endocrinol       Date:  2011-01-10

4.  Physical, social and societal functioning of children with congenital adrenal hyperplasia (CAH) and their parents, in a Dutch population.

Authors:  Sarita A Sanches; Therese A Wiegers; Barto J Otten; Hedi L Claahsen-van der Grinten
Journal:  Int J Pediatr Endocrinol       Date:  2012-02-02

5.  Congenital adrenal hyperplasia.

Authors:  Cleo Dessinioti; Andreas Katsambas
Journal:  Dermatoendocrinol       Date:  2009-03-01

Review 6.  Genes and Pseudogenes: Complexity of the RCCX Locus and Disease.

Authors:  Cinzia Carrozza; Laura Foca; Elisa De Paolis; Paola Concolino
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-30       Impact factor: 5.555

7.  A Gigantic Uterine Leiomyoma and Big Bilateral Adrenal Myelolipomas as a Result of Untreated Congenital Adrenal Hyperplasia.

Authors:  Betty La; Celestine Tung; Eugene A Choi; Ha Nguyen
Journal:  AACE Clin Case Rep       Date:  2021-05-13

8.  A new CYP21A1P/CYP21A2 chimeric gene identified in an Italian woman suffering from classical congenital adrenal hyperplasia form.

Authors:  Paola Concolino; Enrica Mello; Angelo Minucci; Emiliano Giardina; Cecilia Zuppi; Vincenzo Toscano; Ettore Capoluongo
Journal:  BMC Med Genet       Date:  2009-07-22       Impact factor: 2.103

Review 9.  Treatment and health outcomes in adults with congenital adrenal hyperplasia.

Authors:  Thang S Han; Brian R Walker; Wiebke Arlt; Richard J Ross
Journal:  Nat Rev Endocrinol       Date:  2013-12-17       Impact factor: 43.330

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.